Web-Based Surveys Can Help Track Infection Outbreaks (CME/CE)

(MedPage Today) — Internet-based surveys — increasingly being used by public health officials to investigate infectious disease outbreaks — are convenient but need careful design and follow-up if they are to be as reliable as telephone surveys, CDC researchers suggested.

Whooping Cough Still Epidemic in California

(MedPage Today) — The pertussis epidemic continues in California, which has seen 5,272 confirmed, probable, and suspected cases as of last week.

FDA Expands Huber Needle Recall

WASHINGTON (MedPage Today) — The FDA has expanded a class I recall — the agency’s most serious — of Huber needles to include all products containing the intravenous device.

Supreme Court Considers Vaccine Injury Case

WASHINGTON (MedPage Today) — The U.S. Supreme Court heard arguments today in a case seeking to sue vaccine maker Wyeth outside the special forum established to assure continued availability of vaccines.

Big Insurers Increase Denials for Preexisting Conditions

WASHINGTON (MedPage Today) — The number of people denied health insurance from four major insurers because of preexisting medical conditions rose by nearly half in the past several years, according to a memo released Tuesday by a congressional committee.

Screening Continues Even for Terminal Cancer Patients (CME/CE, with video)

(MedPage Today) — Many Medicare patients with advanced, poor-prognosis cancers still undergo routine screening with tests such as Pap smears, mammograms, cholesterol, and PSA tests — despite the improbability of such tests being beneficial — results of a large study showed.

Company Halts ‘Female Viagra’ Development

WASHINGTON (MedPage Today) — The German pharmaceutical company Boehringer Ingelheim announced it is halting development of flibanserin (Girosa), a pill to treat female hypoactive sexual-desire disorder (HSDD).

Vaccine and Drug Safety Top Parents’ Research Priorities

(MedPage Today) — When it comes to medical research related to children’s health, parents view the safety of vaccines and drugs as the most important areas on which to focus, researchers found.

New Tx Okayed for Opioid Addiction

(MedPage Today) — The FDA has added opioid dependence as an indication for long-acting naltrexone (Vivitrol), a once-monthly injectable.

FDA Expands Huber Needle Recall

WASHINGTON (MedPage Today) — The FDA has expanded a class I recall — the agency’s most serious — of Huber needles to include all products containing the intravenous device.